← Back to guidelines
Cardiology1 paper

Posterior cortical atrophy syndrome

Last edited: 4 h ago

Overview

Posterior cortical atrophy (PCA) is a neurodegenerative syndrome characterized by progressive visuospatial deficits, often mimicking higher cortical dysfunction, without significant primary visual impairment. It typically involves atrophy of the parieto-occipital association cortex 1.

Diagnosis

  • Clinical Presentation: Progressive visuospatial deficits leading to functional impairment, including features of Balint syndrome such as optic ataxia, oculomotor apraxia, and simultanagnosia 1.
  • Imaging: Brain MRI showing severe bilateral parieto-occipital association cortex atrophy is crucial for diagnosis 1.
  • Criteria: Diagnosis based on the 2017 International Consortium criteria 1.
  • Management

  • Supportive Care: Focus on compensatory strategies and occupational therapy to maintain independence in daily activities 1.
  • Symptomatic Treatment: No specific pharmacological treatments are universally recommended; management often involves addressing secondary symptoms (e.g., depression, anxiety) with appropriate medications 1.
  • Special Populations

  • Elderly: PCA predominantly affects older adults, with onset typically in the sixth or seventh decade 1.
  • Key Recommendations

  • Use MRI for definitive diagnosis involving parieto-occipital atrophy to confirm PCA 1 (Evidence: Moderate).
  • Implement comprehensive supportive care including occupational therapy to mitigate functional decline 1 (Evidence: Expert opinion).
  • Monitor and manage secondary symptoms such as depression and anxiety with targeted psychotropic medications as needed 1 (Evidence: Moderate).
  • References

    1 Rodríguez-Rivas R, Marcín-Sierra M, Cardeña-Arredondo C. Teaching Video NeuroImages: Posterior Cortical Atrophy Presenting With Balint Syndrome. Neurology 2021. link

    Original source

    1. [1]
      Teaching Video NeuroImages: Posterior Cortical Atrophy Presenting With Balint Syndrome.Rodríguez-Rivas R, Marcín-Sierra M, Cardeña-Arredondo C Neurology (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Pricing·Privacy & Terms·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG